Company Analysis

Agios Pharmaceuticals, Inc. (AGIO)

Nasdaq: AGIO · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 2008
Grade5.6
◀ Past 5.8● Present 5.9▶ Future 5.0
1 est.

Who runs Agios Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Fouse Jacqualyn A
Chief Executive Officer. First filing Dec 2017, latest Jun 23, 2026, 6 filings in all.
Officers reporting now
8
of 16 people with a filing in the last fifteen months
Directors reporting now
8
35 people on the record since 2013
Officerssales are open-market, Oct 28, 2025 to Oct 28, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Gheuens SarahChief Medical OfficerSep 2021Oct 28, 202612 · $1.9M
Fouse Jacqualyn AChief Executive OfficerDec 2017Jun 23, 2026none
Goff BrianChief Executive OfficerAug 2022Jun 23, 20267 · $1.7M
Jones CeciliaChief Financial OfficerSep 2022Jun 23, 20266 · $300,000
Burns James WilliamChief Legal OfficerJan 2022Jun 23, 20266 · $300,000
Milanova TsvetaChief Commercial OfficerJan 2023Jun 23, 20265 · $400,000
Viswanadhan KrishnanChief Strategy and OperationsMar 2025Jun 23, 20262 · $200,000
Washburn Theodore James Jr.Principal Accounting OfficerAug 2021Mar 5, 20264 · $200,000
Directorssales are open-market, Oct 28, 2025 to Oct 28, 2026
NameRoleFirst filingLatest filingSales, 12 months
Backstrom Jay T.directorJul 2025Jul 10, 2026none
Ballal Rahul D.directorAug 2022Jun 23, 2026none
Capello Jeffrey DdirectorJun 2023Jun 23, 2026none
Foster-Cheek Kaye IdirectorDec 2014Jun 23, 2026none
Ho MaykindirectorJun 2015Jun 23, 2026none
Owen Catherine E.directorJun 2023Jun 23, 2026none
Scadden DaviddirectorMay 2017Jun 23, 20261 · $0.00
Smith CynthiadirectorAug 2022Jun 23, 2026none
Earlier names on the record23, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton AGIO · research, not advice